Friday 11 April 2025 01:54 GMT

Eupraxia Pharmaceuticals Inc.


(MENAFN- Baystreet) 09:43 AM EST - Eupraxia Pharmaceuticals Inc. : Today announced that it has appointed Alex Rothwell as the Company's new Chief Financial Officer, effective immediately. Eupraxia Pharmaceuticals Inc. shares T are trading unchanged at $4.53.

MENAFN20022025000212011056ID1109228315


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search